My watch list
my.chemeurope.com  
Login  

Sartorius Supervisory Board appoints two new Executive Board members

10-Dec-2018

Copyright: Sartorius

René Fáber

Copyright: Sartorius

Gerry Mackay

The Supervisory Board of Sartorius AG resolved to make changes in the Executive Board. Effective January 1, 2019, Dr. René Fáber as Head of the Bioprocess Solutions Division and Gerry Mackay as Head of the Lab Products & Services Division will be appointed new members of the company’s Executive Board.

René Fáber, age 43, has been working at Sartorius since 2002. He started as an R&D Scientist in the Membrane Modification Department, then headed R&D Process Technologies. Later, as Vice President, he held various management positions in Marketing for Filtration and Fermentation Technologies, as well as in Key Account Management. In his most recent position before his appointment to the Executive Board, he was responsible for the entire Product Development unit of the Bioprocess Solutions Division. René Fáber studied chemistry in Bratislava, Slovakia, and earned his Ph.D. in polymer chemistry at the Technical University of Munich in Germany. He is of Slovakian nationality.

Gerry Mackay, age 56, joined Sartorius in 2015 from the acquisition of BioOutsource, where he had been its CEO since 2009. Prior to his tenure with BioOutsource, he held international senior level positions in Sales and Marketing at several companies, among them at the U.S. life science company Millipore. At Sartorius, Gerry Mackay as Head of Marketing, Sales and Services of the Lab Products & Services Division drove the momentum of the division‘s new strategic direction towards the biopharmaceutical market and its respective applications and technologies. Gerry Mackay holds a Bachelor’s of Science Honors degree in biochemistry and a Master’s in education, and is of British nationality.

Furthermore, the Supervisory Board and Executive Board member Reinhard Vogt mutually and amicably agreed on the best of terms that the latter will step down from his position on the Executive Board as of December 31, 2018. The Supervisory Board thanks him for his extraordinarily successful service that he has dedicated to the benefit of the company for more than 35 years in various functions, the most recent of which as a member of the Executive Board since 2009. “Mr. Vogt has outstandingly served the company, especially in the strategic alignment and operational leadership of the Bioprocess Solutions Division, which today represents the largest pillar in sales revenue and earnings of the Sartorius Group. We wish Mr. Vogt all the best for the future, in which he will continue to support Sartorius, among other companies, in an advisory capacity,” said Dr. Lothar Kappich, Chairman of the Supervisory Board. “At the same time, we are also pleased to welcome René Fáber and Gerry Mackay, two internationally experienced and successful managers from our own ranks, to join our Executive Board.“

As of January 1, 2019, the Sartorius Executive Board will thus consist of the four following members: Dr. Joachim Kreuzburg (Chairman and CEO); Dr. René Fáber (Head of Bioprocess Solutions), Gerry Mackay (Head of Lab Products & Services); and Rainer Lehmann (Chief Financial Officer).

Facts, background information, dossiers
  • executive board
  • Sartorius
  • appointments
More about Sartorius
  • News

    Sartorius increases sales revenue and earnings in 2018 by double digits

    Sartorius continued on the growth track in 2018 in both divisions and across all geographies, and thus achieved its forecast raised considerably at mid-year. According to preliminary figures, Group sales revenue rose in constant currencies by 13.2% to 1,566.0 million euros (reported: 11.5%) ... more

    Sartorius continues to grow by double digits

    Sartorius continued on the growth track, with double-digit gains in sales revenue and earnings. “In the first nine months of 2018, Sartorius achieved excellent organic growth,” said Dr. Joachim Kreuzburg, Chief Executive Officer. “This applies particularly to the Bioprocess Solutions Divisi ... more

    Sartorius starts off fiscal 2018 successfully

    Sartorius looks back on a successful first quarter 2018. "Both divisions started off the year strongly in line with our expectations and further increased their revenues in the first quarter of 2018 in all regions. On the currency side, however, we faced some headwinds, especially due to th ... more

  • White papers

    Application-specific Membrane Prefilters for Highly Efficient Processes in Biopharmaceutical Production

    New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are required in biopharmaceutical production. In order to more

    Filter Integrity Testing

    The integrity testing of sterile filters constitutes a critical and mandatory regulatory step in biopharmaceutical production processes. However, performing such filter integrity tests costs time. Indeed, it can take a good 20 to 30 minutes to perfor more

    Quality Control in the Production of High-Quality Plastic Parts

    The customer, Tien Phong Plastic JSC, a leading Vietnamese manufacturer of plastic parts, was seeking an option for the precise, fast and simple measurement of moisture levels in plastic granules during receipt of goods and production. The aim was to more

  • Companies

    Sartorius AG

    Sartorius is one of the world's leading providers of laboratory and process technologies and equipment. Our innovative products and high-quality services help customers around the globe implement complex and quality-critical processes in biopharmaceutical production and laboratory environme ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE